Actinogen Medical Ltd: ACW June 2024 quarterly activity report & Appendix 4C
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Results of Meeting
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: ACW XanaCIDD depression trial results expected early August
Actinogen Medical Ltd: Positive Xanamem biomarker trial published in Jnl Alz Dis
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Letter to Shareholders, Notice of GM & Proxy Form
Actinogen Medical Ltd: Appendix 3Ys x 5
Actinogen Medical Ltd: Notification regarding unquoted securities - ACW
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: ACW Oversubscribed $3.9 million entitlement offer completed
Actinogen Medical Ltd: ACW poster presentation at ADRF conference 2024
Actinogen Medical Ltd: Actinogen entitlement offer closed and oversubscribed
Actinogen Medical Ltd: ACW Clinical Trials Science Forum slides & registration
Actinogen Medical Ltd: Change in substantial holding
No Data